Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma

doi:10.4254/wjh.v5.i7.364

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5877)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

380

HTML

2982

Figures (1-1)

302

Tables (1-5)

252

Sum=3916

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1025

Download

936

Sum=1961

Jul 27, 2013 (publication date) through Feb 6, 2025

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Jul 27, 2013; 5(7): 364-371
Published online Jul 27, 2013. doi: 10.4254/wjh.v5.i7.364

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival. A: Kaplan-Meier overall survival for transarterial chemoembolization (TACE) alone and TACE + sorafenib; B: Kaplan-Meier progression-free survival for TACE alone and TACE + sorafenib.

Citation: Muhammad A, Dhamija M, Vidyarthi G, Amodeo D, Boyd W, Miladinovic B, Kumar A. Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma. World J Hepatol 2013; 5(7): 364-371
URL: https://www.wjgnet.com/1948-5182/full/v5/i7/364.htm
DOI: https://dx.doi.org/10.4254/wjh.v5.i7.364